Tejnaksh Healthcare Ltd

On 03-Dec, Tejnaksh Healthcare Ltd witnessed a significant decline in its share price, closing at ₹15.60, down ₹0.76 or 4.65% from the previous session. This drop reflects a continuation of a downward trend that has persisted over recent weeks, highlighting ongoing challenges for the stock amid broader market conditions.

Tejnaksh Health's historical performance shows fluctuating net sales and profits, with a decline from Mar'19 to Mar'20, followed by recovery; net sales rose to 12.90 Cr in Mar'25 from 11.73 Cr in Mar'23, but cash flow from operations dropped to 0.00 Cr in Mar'25, indicating challenges despite improved profits.

Tejnaksh Health's historical performance shows fluctuating net sales, increasing from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, but down from a peak of 19.76 Cr in Mar'19. While profitability has improved, total assets and sales remain below historical highs.

As of 18-Nov, Tejnaksh Healthcare Ltd's stock price is Rs 16.50, down 1.61%, and has declined 3.34% over the last two days. The stock is underperforming significantly compared to the Sensex, trading below all major moving averages and nearing its 52-week low.

Tejnaksh Health has shown a recovery in net sales and profits from Mar'21 onwards, with net sales increasing from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, while profit after tax rose from 1.79 Cr to 2.23 Cr in the same period. However, total operating income peaked in Mar'19 and has since declined, alongside rising operational costs and a decrease in total liabilities.

Tejnaksh Health's historical performance shows fluctuating net sales and profits, with a recovery from a decline between Mar'20 and Mar'21. As of Mar'25, net sales reached 12.90 Cr, operating profit improved to 4.08 Cr, and profit after tax was 2.23 Cr, despite challenges in revenue growth and cash flow management.

Tejnaksh Healthcare's latest results are concerning, showing a 15.38% decline in net sales and a 43.93% drop in operating profit compared to the previous year, indicating significant operational challenges. Key metrics like profit before tax and earnings per share have also decreased, reflecting a tough financial environment for the company.

Tejnaksh Health has shown fluctuating financial performance, with net sales increasing from INR 11.73 crore in March 2023 to INR 12.90 crore in March 2025, and profitability improving, as profit after tax rose to INR 2.23 crore in March 2025. However, total assets and liabilities decreased, and cash flow from operating activities dropped to zero in March 2025.

Tejnaksh Health's historical performance shows fluctuating financial metrics, with net sales increasing from INR 11.73 crore in March 2023 to INR 12.90 crore in March 2025, while profitability improved but cash flow from operations dropped to zero in March 2025. Overall, the company has faced mixed results, with some gains in profitability but challenges in cash flow management.

As of 15-Oct, Tejnaksh Healthcare Ltd's stock price is Rs. 17.85, up 2.59% today but has hit a new 52-week low of Rs. 16.25, reflecting ongoing challenges and a year-to-date decline of 20.70%. The stock has underperformed the Sensex, which gained 1.02% over the past week, indicating a bearish trend and decreased investor participation.